PH31433A - Ranitidine compositions. - Google Patents

Ranitidine compositions.

Info

Publication number
PH31433A
PH31433A PH47062A PH47062A PH31433A PH 31433 A PH31433 A PH 31433A PH 47062 A PH47062 A PH 47062A PH 47062 A PH47062 A PH 47062A PH 31433 A PH31433 A PH 31433A
Authority
PH
Philippines
Prior art keywords
ranitidine
compositions
ranitidine compositions
advantage
treatment
Prior art date
Application number
PH47062A
Other languages
English (en)
Inventor
Bye Allan
Laurenc F Lacey
Evans Jill
Paul D Huckle
Peter J Rue
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of PH31433A publication Critical patent/PH31433A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PH47062A 1992-10-13 1993-10-11 Ranitidine compositions. PH31433A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929221414A GB9221414D0 (en) 1992-10-13 1992-10-13 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
PH31433A true PH31433A (en) 1998-11-03

Family

ID=10723323

Family Applications (1)

Application Number Title Priority Date Filing Date
PH47062A PH31433A (en) 1992-10-13 1993-10-11 Ranitidine compositions.

Country Status (25)

Country Link
US (1) US5593685A (no)
EP (2) EP0788789A1 (no)
JP (1) JP2918691B2 (no)
KR (1) KR950703327A (no)
AT (1) ATE166572T1 (no)
AU (1) AU676690B2 (no)
BG (1) BG99567A (no)
CA (1) CA2147000A1 (no)
CZ (1) CZ94495A3 (no)
DE (1) DE69318844T2 (no)
ES (1) ES2117718T3 (no)
GB (1) GB9221414D0 (no)
HU (2) HUT72497A (no)
IL (1) IL107255A (no)
MX (1) MX9306333A (no)
NO (1) NO951432L (no)
NZ (1) NZ256681A (no)
OA (1) OA10144A (no)
PH (1) PH31433A (no)
PL (1) PL174359B1 (no)
SG (1) SG49850A1 (no)
SK (1) SK48395A3 (no)
TW (1) TW271405B (no)
WO (1) WO1994008560A1 (no)
ZA (1) ZA937544B (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622980A (en) * 1993-08-17 1997-04-22 Applied Analytical Industries, Inc. Oral compositions of H2-antagonists
GB9418530D0 (en) * 1994-09-14 1994-11-02 Glaxo Group Ltd Medicaments
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
AU7468096A (en) * 1995-10-30 1997-05-22 Warner-Lambert Company Enhanced anti-inflammatory oral composition containing h2 receptor antagonist and antimicrobial oils
DE19639343C2 (de) 1996-09-25 1998-10-08 Suedzucker Ag Komprimate, enthaltend ein Süßungsmittelgemisch
GB9715423D0 (en) * 1997-07-23 1997-09-24 Glaxo Group Ltd Aqueous compositions
US6086920A (en) * 1998-08-12 2000-07-11 Fuisz Technologies Ltd. Disintegratable microspheres
US7163705B2 (en) * 1998-12-15 2007-01-16 Wm. Wrigley Jr. Company Coated chewing gum product and method of making
US6627234B1 (en) 1998-12-15 2003-09-30 Wm. Wrigley Jr. Company Method of producing active agent coated chewing gum products
US6586023B1 (en) 1998-12-15 2003-07-01 Wm. Wrigley Jr. Company Process for controlling release of active agents from a chewing gum coating and product thereof
US6531114B1 (en) 1999-04-06 2003-03-11 Wm. Wrigley Jr. Company Sildenafil citrate chewing gum formulations and methods of using the same
US6270807B1 (en) 1999-03-02 2001-08-07 L. Perrigo Company Taste-masked pharmaceutical composition
US6426090B1 (en) * 1999-04-06 2002-07-30 Wm. Wrigley Jr. Company Over-coated product including tableted center and medicament
US20020159956A1 (en) * 1999-04-06 2002-10-31 Ream Ronald L. Over-coated chewing gum formulations
US6322806B1 (en) 1999-04-06 2001-11-27 Wm. Wrigley Jr. Company Over-coated chewing gum formulations including tableted center
US7935362B2 (en) * 1999-04-06 2011-05-03 Wm. Wrigley Jr. Company Over-coated product including consumable center and medicament
US6773716B2 (en) 1999-04-06 2004-08-10 Wm. Wrigley Jr. Company Over-coated chewing gum formulations
US6355265B1 (en) 1999-04-06 2002-03-12 Wm. Wrigley Jr. Company Over-coated chewing gum formulations
US6645535B2 (en) 1999-09-02 2003-11-11 Wm. Wrigley Jr. Company Method of making coated chewing gum products containing various antacids
US6541048B2 (en) 1999-09-02 2003-04-01 Wm. Wrigley Jr. Company Coated chewing gum products containing an acid blocker and process of preparing
US6569472B1 (en) 2000-09-01 2003-05-27 Wm. Wrigley Jr. Company Coated chewing gum products containing antacid and method of making
US6663849B1 (en) 2000-09-01 2003-12-16 Wm. Wrigley Jr. Company Antacid chewing gum products coated with high viscosity materials
WO2001021147A1 (en) * 1999-09-20 2001-03-29 Mastercare Diet and weight control gum and sucker
US9253991B2 (en) 1999-09-20 2016-02-09 Jack Barreca Chewing gum with B vitamins
US9387168B2 (en) 1999-09-20 2016-07-12 Jack Barreca Chewing gum with tomatidine
US6572900B1 (en) 2000-06-09 2003-06-03 Wm. Wrigley, Jr. Company Method for making coated chewing gum products including a high-intensity sweetener
US7115288B2 (en) * 2000-06-09 2006-10-03 Wm. Wrigley Jr. Company Method for making coated chewing gum products with a coating including an aldehyde flavor and a dipeptide sweetener
US6444241B1 (en) 2000-08-30 2002-09-03 Wm. Wrigley Jr. Company Caffeine coated chewing gum product and process of making
US6579545B2 (en) 2000-12-22 2003-06-17 Wm. Wrigley Jr. Company Coated chewing gum products containing an antigas agent
JP5412966B2 (ja) * 2009-06-08 2014-02-12 ライオン株式会社 粒状製剤
CN109010303B (zh) * 2017-06-09 2021-05-07 苏州科伦药物研究有限公司 一种盐酸雷尼替丁胶囊的工业制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0349103B1 (en) * 1988-05-04 1992-11-25 Smith Kline & French Laboratories Limited Chewable tablet
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it
CH679373A5 (no) * 1988-09-20 1992-02-14 Glaxo Group Ltd
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
NZ235877A (en) * 1989-11-02 1992-09-25 Mcneil Ppc Inc Composition comprising acetaminophen or nsaid and an h 1 or h 2 receptor blocker and/or proton pump inhibitor for treating overindulgence
US5075114A (en) * 1990-05-23 1991-12-24 Mcneil-Ppc, Inc. Taste masking and sustained release coatings for pharmaceuticals
CA2052679C (en) * 1990-08-30 1997-12-02 Edward J. Roche Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
SK121293A3 (en) * 1991-04-04 1994-07-06 Procter & Gamble Ingestible pharmaceutical compositions for treating upper gastrointestinal tract disorder
CA2106216C (en) * 1991-04-04 1997-06-10 Paul Randolph Court Chewable antacid compositions
JP2948317B2 (ja) * 1991-05-28 1999-09-13 マクニール―ピーピーシー・インコーポレーテツド 噛める薬物投与用組成物
CA2068402C (en) * 1991-06-14 1998-09-22 Michael R. Hoy Taste mask coatings for preparation of chewable pharmaceutical tablets
CA2079934C (en) * 1991-10-15 2002-09-03 Edward J. Roche Taste mask coatings for preparing chewable pharmaceutical tablets
US5229137A (en) * 1992-05-06 1993-07-20 Brigham And Women's Hospital, Inc. Methods and pharmaceutical compositions for treating episodic heartburn

Also Published As

Publication number Publication date
BG99567A (en) 1995-12-29
CA2147000A1 (en) 1994-04-28
JP2918691B2 (ja) 1999-07-12
NO951432L (no) 1995-05-12
AU676690B2 (en) 1997-03-20
DE69318844D1 (de) 1998-07-02
NO951432D0 (no) 1995-04-12
PL174359B1 (pl) 1998-07-31
MX9306333A (es) 1995-01-31
HU211847A9 (en) 1995-12-28
HUT72497A (en) 1996-05-28
NZ256681A (en) 1997-10-24
GB9221414D0 (en) 1992-11-25
IL107255A (en) 1998-07-15
CZ94495A3 (en) 1995-10-18
JPH08502272A (ja) 1996-03-12
WO1994008560A1 (en) 1994-04-28
EP0788789A1 (en) 1997-08-13
SG49850A1 (en) 1998-06-15
OA10144A (en) 1996-12-18
AU5143493A (en) 1994-05-09
ATE166572T1 (de) 1998-06-15
PL308356A1 (en) 1995-07-24
IL107255A0 (en) 1994-01-25
KR950703327A (ko) 1995-09-20
US5593685A (en) 1997-01-14
HU9501053D0 (en) 1995-06-28
ES2117718T3 (es) 1998-08-16
TW271405B (no) 1996-03-01
DE69318844T2 (de) 1998-10-15
ZA937544B (en) 1994-04-21
SK48395A3 (en) 1995-11-08
EP0664697A1 (en) 1995-08-02
EP0664697B1 (en) 1998-05-27

Similar Documents

Publication Publication Date Title
SG49850A1 (en) Ranitidine compositions
ATE184789T1 (de) Verwendung von carnosolsäure wegen seiner anticarcinogenen und antiviralen eigenschaften
NZ225770A (en) Compositions of substituted 1,2,3-triazoles
ZA884484B (en) Essential fatty acid compositions
IL97749A0 (en) Method of stabilizing isothiazolones by the use of phenoxy-alkanols and stabilized compositions of isothiazolones comprising phenoxyalkanols
EP0328634A4 (en) Pharmaceutical compositions for the treatment of psoriasis
TW267161B (no)
EP0340391A3 (en) 1,4-disubstituted-2,3,4,6-tetrahydroxy-1,4-diphosphorinane and their oxides or sulfides
PH24094A (en) 5-aryl-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
EP0635010A1 (en) NEW CARDIOPROTECTIVE AGENTS.
EP0556546A3 (en) Viricidal disinfecting composition
NZ214449A (en) 13-alpha-alkylgonanes and pharmaceutical compositions
ZA931062B (en) Compositions for the treatment of glaucoma.